Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Correlation Between Cognitive Functions and MRI in Multiple Sclerosis
This study is currently recruiting participants.
Verified by Sheba Medical Center, September 2007
Sponsored by: Sheba Medical Center
Information provided by: Sheba Medical Center
ClinicalTrials.gov Identifier: NCT00423111
  Purpose

The purpose of this study is to determine whether there is a correlation between cognitive functions and volume of specific brain area measured in MRI of multiple sclerosis patients.


Condition
Multiple Sclerosis

MedlinePlus related topics: Multiple Sclerosis
U.S. FDA Resources
Study Type: Observational
Study Design: Natural History, Longitudinal, Convenience Sample, Retrospective/Prospective Study

Further study details as provided by Sheba Medical Center:

Estimated Enrollment: 100
Study Start Date: February 2007
Estimated Study Completion Date: February 2009
Detailed Description:

Recent literature suggests that multiple sclerosis is accompanied by significant deficits in cognitive performance. The origin of these cognitive deficits is not known, since the severity of cognitive deficits was not found to be correlated with disease parameters such as duration, lesion load or disease intensity as measured on standard scales (e.g. EDSS). The research hypothesis we plan to test is that the individual intensity of cognitive deficits is correlated with degeneration of specific neuronal structures related to cognitive performance, such as the hippocampus and prefrontal cortex.

To test this hypothesis, we plan to perform volumetric measurements of such regions on MRI scans obtained from MS patients during the course of their clinical evaluation, and attempt to correlate those with the results of neuropsychological tests performed by the same subjects around the time of MRI scanning.

  Eligibility

Ages Eligible for Study:   18 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Clinical diagnosis of Multiple Sclerosis
  • Age 18-65

Exclusion Criteria:

  • Another brain disease
  • Stroke
  • Brain trauma
  • Neurosurgery
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00423111

Contacts
Contact: Yael Deri, BSc 972 508273381 yaelderi@gmail.com
Contact: Anat Biegon, Ph.D 972 52666177 anat.biegon@sheba.health.gov.il

Locations
Israel
Sheba Medical Center Recruiting
Ramat Gan, Israel, 52621
Sponsors and Collaborators
Sheba Medical Center
Investigators
Principal Investigator: Anat Achiron, MD Ph.D Sheba Medical Center
  More Information

Study ID Numbers: SHEBA-06-4487-AA-CTIL
Study First Received: January 15, 2007
Last Updated: September 20, 2007
ClinicalTrials.gov Identifier: NCT00423111  
Health Authority: Israel: Israeli Health Ministry Pharmaceutical Administration

Keywords provided by Sheba Medical Center:
Multiple sclerosis
Memory
Cognitive deficits
MRI
Hippocampus
Prefrontal cortex

Study placed in the following topic categories:
Autoimmune Diseases
Multiple Sclerosis
Demyelinating Diseases
Demyelinating Autoimmune Diseases, CNS
Demyelinating diseases
Sclerosis
Autoimmune Diseases of the Nervous System

Additional relevant MeSH terms:
Pathologic Processes
Immune System Diseases
Nervous System Diseases

ClinicalTrials.gov processed this record on January 14, 2009